US Map / Texas
State TX

Clinical Trials in Texas

Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.

Total Trials
736
Recruiting Now
736
← Back to US Map
Top Conditions in Texas
Breast Cancer (17)Prostate Cancer (15)Colorectal Cancer (12)Advanced Solid Tumors (11)Advanced Solid Tumor (11)Acute Myeloid Leukemia (10)Ovarian Cancer (10)Endometrial Cancer (9)Asthma (8)Multiple Myeloma (7)Cancer (7)Chronic Lymphocytic Leukemia (7)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 736 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 736. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT06908356 Phase 2
Recruiting
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults Wi...
Condition
Focal Onset Seizure
Enrollment
50 pts
Location
United States, Australia, Spain
Sponsor
Praxis Precision Medicines
View Trial →
NCT06376162 Phase 1
Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractor...
Condition
Relapsed/Refractory KMT2A-r Acute Leukemia
Enrollment
20 pts
Location
United States, Austria, Canada
Sponsor
PedAL BCU, LLC
View Trial →
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
View Trial →
NCT06010329 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Loca...
Condition
Non-small Cell Lung Cancer
Enrollment
66 pts
Location
United States
Sponsor
Teligene US
View Trial →
NCT06926920 Phase 1, Phase 2
Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Pa...
Condition
Triple Negative Breast Cancer
Enrollment
100 pts
Location
United States, Australia, South Korea
Sponsor
Gilead Sciences
View Trial →
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
View Trial →
NCT06958796 Phase 4
Recruiting
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Condition
Cytomegalovirus
Enrollment
80 pts
Location
United States
Sponsor
Camille N. Kotton, MD
View Trial →
NCT07358546 Phase 1
Recruiting
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Condition
Non-alcoholic Fatty Liver Disease
Enrollment
32 pts
Location
United States
Sponsor
GlaxoSmithKline
View Trial →
NCT06869551 Phase 3
Recruiting
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BM...
Condition
Juvenile Psoriatic Arthritis
Enrollment
60 pts
Location
United States, Brazil, Bulgaria
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06165341 Phase 3
Recruiting
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alp...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
50 pts
Location
United States, Austria, Belgium
Sponsor
Takeda
View Trial →
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
View Trial →
NCT07538570 Phase 4
Recruiting
Evaluation of Pain Treatment After Total Knee Arthroplasty
Condition
Pain
Enrollment
60 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07565454 N/A
Recruiting
Evaluation of Hepato-Pancreato-Biliary
Condition
Gastro-Intestinal Disorder
Enrollment
100 pts
Location
United States
Sponsor
Methodist Health System
View Trial →
NCT07015905 Phase 3
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee ...
Condition
Venous Thromboembolism (VTE)
Enrollment
2,000 pts
Location
United States, Bulgaria, Hungary
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
View Trial →
NCT05647122 Phase 1
Recruiting
First in Human Study of AZD9592 in Solid Tumors
Condition
Advanced Solid Tumours
Enrollment
403 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sl...
Condition
Obesity
Enrollment
250 pts
Location
United States, Australia, Brazil
Sponsor
Amgen
View Trial →
NCT07136779 Phase 1, Phase 2
Recruiting
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Maligna...
Condition
Participants With Advanced Solid Tumor Malignancies
Enrollment
310 pts
Location
United States
Sponsor
VelaVigo Bio Inc
View Trial →
NCT02781883 Phase 2
Recruiting
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in ...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
108 pts
Location
United States
Sponsor
Bio-Path Holdings, Inc.
View Trial →
NCT07191483 Phase 2
Recruiting
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With...
Condition
Cognitive Impairment Associated With Schizophrenia (CIAS)
Enrollment
150 pts
Location
United States
Sponsor
Kynexis B.V.
View Trial →
NCT05238922 Phase 1
Recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
604 pts
Location
United States, France, Italy
Sponsor
Incyte Corporation
View Trial →
NCT05836259 Phase 1, Phase 2
Recruiting
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability...
Condition
Hypertrophic Cardiomyopathy
Enrollment
30 pts
Location
United States
Sponsor
Tenaya Therapeutics
View Trial →
NCT06671886 N/A
Recruiting
NAFLD Clinical Care Pathway
Condition
NAFLD
Enrollment
32 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT03096366 N/A
Recruiting
Does Blood Flow Restriction Training Improve Quadriceps Function After Arthrosco...
Condition
Quadriceps Atrophy
Enrollment
150 pts
Location
United States
Sponsor
The University of Texas Health
View Trial →
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
View Trial →
Page 4 of 30 — 736 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology